TNF and Insulin resistance: Supporting this hypothesis, two reports indicated that pioglitazone, a peroxisome proliferator-activated receptor-γ (PPARγ) agonist reduced TNF-α-mediated IRS1Ser307 phosphorylation and insulin resistance in diabetic rat retinas, with a concomitant improvement in retinal function [55].